medline.ch Neurologie Alzheimer

	Efficacy of Non-Invasive Brain Stimulation in Alzheimer's Disease: An Umbrella Review of Meta-Analyses. Neurosci Biobehav Rev Tang Y, Huang L, Li W, Gao T, Shi N, Zhu Y, Wang Y, Nan J, Zhu Y, Li J, Ma Y. PMID: 42398685 [PubMed - as supplied by publisher]
	Combined transformer encoder-CNN architecture with texture features for MRI-based Alzheimer's disease detection. Psychiatry Res Neuroimaging Jyothi GD, Kumar CM, Kottala RK. PMID: 42398294 [PubMed - as supplied by publisher]
	Pharmacotherapy for Alzheimer's Disease and Dementias in Long-Term Care: A Real-World EHR Study. J Am Med Dir Assoc Saumur TM, Ashraf H, Mathers KE, Wagner B. PMID: 42398193 [PubMed - as supplied by publisher]
	HDAC11 as a potential therapeutic target for Alzheimer's disease. Drug Discov Today Zhang W, Wang Y, Tocci D, Wang C, Zhang C. PMID: 42398801 [PubMed - as supplied by publisher]
	Real-Time Smartphone Monitoring Assessments as a Cognitive Biomarker of Alzheimer Disease: Protocol for a Development Study. JMIR Res Protoc McKenna M, Torous J, Rozenblit E, Flathers M, Ryan S, Byun AJS, Lim C. PMID: 42398039 [PubMed - indexed for MEDLINE]
	Targeted nanomedicine strategies for Alzheimer's disease therapy. Discov Nano Ardah MT, Yaseen BM, Malathi H, Ray S, Thyagarajan R, Shankhyan A, Eshmetov R, Ataullaev Z, Mishra MK. PMID: 42397646 [PubMed]
	Exercise and fluoxetine in Alzheimer's disease: Molecular mechanisms of synergistic and antagonistic effects (Review). Int J Mol Med Wu M, Li Y. PMID: 42396669 [PubMed - indexed for MEDLINE]
	Source-Free Active Learning for Adapting Alzheimer's Diagnostic Deep Learning Models Across Neuroimaging Cohorts. IEEE EMBS Int Conf Biomed Health Inform Ganitidis T, Vlontzou ME, Athanasiou M, Nikita KS, Davatzikos C. PMID: 42396431 [PubMed]
	MCH-Guard: Multimodal Machine Learning Framework for Risk Stratification of Cerebral Microhemorrhage Risk in the Alzheimer's Disease Neuroimaging Initiative. medRxiv Gel A, Phillips E, Hausle I, Thropp P, Tosun D, Alzheimer. PMID: 42396347 [PubMed]
	Changes in Plasma Amyloid Î² 1-42 Peptide and Total Tau Protein from Normal Cognition to Sever-Stage Alzheimer's Disease Using an Immunomagnetic Reduction Assay. ACS Omega Yang SY, Liu HC, Chiu MJ, Chang JF, Ho CS, Lee KH. PMID: 42396039 [PubMed]
	Multiracial participants in Alzheimer's research: scoping review and recommendations. Alzheimers Dement (N Y) Moeller S, Singsank K, Goodwin G, Lafont-Tanner D, Lawrence E, Renn B, John S. PMID: 42395838 [PubMed]
	FLOT1 and EEF1D: ac4C-related genes bridging Alzheimer's disease and sleep deprivation. Front Aging Neurosci Zhao B, Zhou R, Liu P, Li Q, Yan Y, Du J, Zhao K, Liu J, Wang J, Qu Q. PMID: 42395345 [PubMed]
	Biomarkers, diagnosis, and the meaning of disease: evaluating competing frameworks for Alzheimer's disease classification. Front Aging Neurosci Terman E. PMID: 42395343 [PubMed]
	Evaluating the User Experience and Therapeutic Efficacy of Humanoid Socially Assistive Robots in Alzheimer's Disease and Related Dementias (ADRD) Care. Stud Health Technol Inform Khan A, Kabir H. PMID: 42394082 [PubMed - indexed for MEDLINE]
	Microglial checkpoint collapse in Alzheimer's disease: a tri-axial framework for biomarker-informed neuroimmune therapy. J Neuroinflammation Zhang J, Yang N, Zou P, Zong X. PMID: 42393750 [PubMed - as supplied by publisher]
	Feasibility and preliminary effects of outdoor versus indoor cognitive-motor therapy in women with Alzheimer's disease: A randomized single-blind pilot study. Sci Rep Vostrý M, Binter J, Ková, Posel Z, Kubová N, Cmorej PC, Kroufek R. PMID: 42393367 [PubMed - as supplied by publisher]
	Bacillus Calmette-GuÃ©rin (BCG) immunotherapy reprograms CNS immunity and alters Alzheimer's biomarkers: results from two open-label clinical trials. Commun Med (Lond) Weinberg MS, Kodali MC, Li Z, Galler JA, Tidball AR, Reynolds WC, Young C, Devitte-McKee K, Fatima HA, Kivisäkk P, Chatterjee M, Kulkarni A, Billingsly JM, Bartlett AL, Sui SH, Kühtreiber WM, Gerber J, McManus AJ, Tanzi RE, Das S, Faustman DL, Arnold SE. PMID: 42393277 [PubMed]
	Gingipains as macromolecular mediators at the periodontal-brain interface: Mechanistic, diagnostic, and therapeutic evidence in Alzheimer's and Parkinson's diseases. Int J Biol Macromol Dhar I, Gupta S, Mishra R, Dadhich A. PMID: 42392383 [PubMed - as supplied by publisher]
	Volumetric postmortem MRI of the medial temporal lobe in Alzheimer's disease and related disorders: methodological advances and implications for in vivo biomarker development. Neuroimage Salman Y, Denning AE, Schaeverbeke JM, Tomé SO, Joudiou N, Khandelwal P, Yushkevich PA, Vandenberghe R, Gallez B, Wisse LE, Hanseeuw BJ. PMID: 42392339 [PubMed - as supplied by publisher]
	"Neurotoxic mechanisms of microplastic compounds in Alzheimer's and Parkinson's diseases: A network toxicology and molecular docking study". Ecotoxicol Environ Saf Sun Z, Peng J, Feng Z, Wang X, Long H, Qi S, Li L, Li M, Yung KKL, Cheung KH, Zhang Z. PMID: 42391846 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 71216

Seite 1 von 3561

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung